Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.05 +0.89 (+1.02%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Share-based Compensation (2017 - 2025)

Updated

Dianthus Therapeutics (DNTH) posted Share-based Compensation of $5.79 million for Q3 2025, up 50.9% from $3.84 million a year earlier and up 1.5% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Share-based Compensation (2017 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, Share-based Compensation at Dianthus Therapeutics was $20.73 million, up 113.7% year-over-year; for FY2024, it came in at $12.89 million, up 344.6% from FY2023.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 5.2% (FY2019 to FY2024).
  • In prior years, Dianthus Therapeutics' Share-based Compensation was $2.9 million in FY2023 (+91.0%), $1.52 million in FY2022 (-85.3%), $10.31 million in FY2021 (+3.7%) and $9.94 million in FY2020 (-0.6%).
  • The Q3 2025 figure stands as the highest quarterly Share-based Compensation in data going back to Q3 2017.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last eight quarters, with growth averaging 232.0% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2024, with growth of 571.2%; the weakest was Q4 2022, with a decline of 76.5%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $5.71 million (Q2 2025), $5.32 million (Q1 2025) and $3.92 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Dianthus Therapeutics 3.77 Bn 3.72 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.79 Mn
Jun 30, 2025 5.71 Mn
Mar 31, 2025 5.32 Mn
Dec 31, 2024 3.92 Mn
Sep 30, 2024 3.84 Mn
Jun 30, 2024 3.10 Mn
Mar 31, 2024 2.04 Mn
Dec 31, 2023 726,000.00
Sep 30, 2023 1.18 Mn
Jun 30, 2023 462,000.00
Mar 31, 2023 533,000.00
Dec 31, 2022 513,000.00
Sep 30, 2022 -2.75 Mn
Jun 30, 2022 1.85 Mn
Mar 31, 2022 1.91 Mn
Dec 31, 2021 2.18 Mn
Sep 30, 2021 3.80 Mn
Jun 30, 2021 2.13 Mn
Mar 31, 2021 2.19 Mn
Dec 31, 2020 2.33 Mn
API Access

Dianthus Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=DNTH&period=max&api_key=YOUR_API_KEY